SCHEMBL6983087

SCHEMBL6983087

CCOC(=O)COc1cc2c(=O)c(C)cn3c4ccc(Br)cc4c(c1)c23

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
MCL1 Q07820 1/20 0.40
ALDH1A1 P00352 3/20 0.38
POLB P06746 2/20 0.38
ADORA2A P29274 1/20 0.38
ADORA2B P29275 1/20 0.38
MAPK1 P28482 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.37
GAA P10253 3/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PABPC1 P11940 1/20 0.37
APOBEC3A P31941 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
GABRA1 P14867 1/20 0.36
GABRB1 P18505 1/20 0.36
GABRA3 P34903 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6975925 0.89 PTGDR2 (0.41) LMNAMEN1KMT2AMCL1ALDH1A1
SCHEMBL6984474 0.88 TNFRSF1A (0.36) LMNAMEN1KMT2AALDH1A1POLB
SCHEMBL6976583 0.88 LMNA (0.40) LMNASMN1; SMN2MCL1ALDH1A1NPSR1
SCHEMBL6971985 0.85 SMN1; SMN2 (0.43) LMNASMN1; SMN2MEN1KMT2AMCL1
SCHEMBL6983182 0.82 TSHR (0.41) LMNASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL6984498 0.81 LMNA (0.36) LMNAMCL1MAPTKDM4E
SCHEMBL6979851 0.80 LMNA (0.41) LMNASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL6975262 0.80 PIK3R1 (0.38) LMNASMN1; SMN2MEN1KMT2AMCL1
SCHEMBL6979263 0.77 LMNA (0.60) LMNASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL6981368 0.77 LMNA (0.38) LMNASMN1; SMN2ALDH1A1NPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0992240-A1 THERAPEUTIC AGENT FOR ERECTION FAILURE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed